• BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Average Rating of "Moderate Buy" by Analysts

    来源: Buzz FX / 20 12月 2024 02:26:12   America/Chicago


    BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Average Rating of "Moderate Buy" by Analysts Written by MarketBeat December 20, 2024 Share Link copied to clipboard. Shares of BioMarin Pharmaceutical Inc.
    Read more...
分享